Status
Conditions
Treatments
About
To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.
To achieve prenatal accurate identification of fetal blood group genotypes,and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).
Full description
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
Sex
Ages
Volunteers
Inclusion criteria
blood samples of pregnant couples,gender/nation/region is unlimited.
Exclusion criteria
adipose or hemolytic samples,overdue samples,unidentified samples
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal